Skip to main content

Advertisement

Log in

Familial risk of urological cancers: data for clinical counseling

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Familial risks for cancer are important for clinical counseling and understanding cancer etiology. The nationwide Swedish Family-Cancer Database includes all Swedes born in 1932 and later (0 to 68-year-old offspring) with their parents, totaling over 10.2 million individuals. Urological cancer cases were retrieved from the Swedish Cancer Registry up to year 2000. Standardized incidence ratios (SIR) and 95% confidence limits (CI) were calculated for age-specific familial risk in offspring by an exact proband status. The familial risks for offspring cancer were increased at all urological sites from concordant cancer in the parent and in a sibling proband. The highest SIRs by parent were for testicular and prostate cancer (4.26 and 2.45). When a sibling was affected, even kidney cancer (4.74) showed a high SIR. For kidney cancers, and also for prostate and testicular cancers, the SIRs were higher among siblings than among offspring and parents, which may indicate the involvement of recessive effects. Family members of patients with prostate cancer or von Hippel Lindau disease can expect organized clinical counseling, but family members of patients with other urological cancers are probably not counseled. Guidelines for clinical counseling or action level should be developed for all urological cancers because of the established familial risks. Urological cancers also offer a challenge to molecular geneticists attempting to identify the susceptibility genes underlying the familial clustering.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Isaacs S, Kiemeney L, Baffo-Bonnie A, Beaty T, Walsh P (1995) Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87:991–996

    CAS  PubMed  Google Scholar 

  2. Ponder B (1997) Genetic testing for cancer risk. Science 278:1050–1054

    Article  CAS  PubMed  Google Scholar 

  3. Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, et al (2002) American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 52:8–22

    PubMed  Google Scholar 

  4. Petersen G, Codori A-M (2002) Genetic testing for familial cancer. In: Vogelstein B, Kinzler K (eds) The genetic basis of human cancer, 2nd edn. McGraw-Hill, New York pp 643–656

  5. Burke W (2002) Genetic testing. New Engl J Med 347:1867–1875

    Article  CAS  PubMed  Google Scholar 

  6. Guttmacher AE, Collins FS (2002) Genomic medicine—a primer. N Engl J Med 347:1512–1520

    Article  CAS  PubMed  Google Scholar 

  7. Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3:209–212

    CAS  PubMed  Google Scholar 

  8. Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6:313–317

    CAS  PubMed  Google Scholar 

  9. Kerber R, Slattery M (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146:244–248

    CAS  PubMed  Google Scholar 

  10. Gibbs M, Stanford J, McIndoe R, Jarvik G, Kolb S, Goode E, et al (1999) Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 64:776–787

    CAS  PubMed  Google Scholar 

  11. Glanz K, Grove J, Le Marchand L, Gotay C (1999) Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev 8:635–639

    CAS  PubMed  Google Scholar 

  12. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148

    Article  CAS  PubMed  Google Scholar 

  13. King T, Tong L, Pack R, Spencer C, Amos C (2002) Accuracy of family history of cancer as reported by men with prostate cancer. Urology 59:546–550

    Article  PubMed  Google Scholar 

  14. Carstensen B, Soll-Johanning H, Villadsen E, Söndergaard J, Lynge E (1996) Familial aggregation of colorectal cancer in the general population. Int J Cancer 68:428–435

    Article  CAS  PubMed  Google Scholar 

  15. Hemminki K, Jiang Y (2002) Familial and second gastric cancers: a nation wide epidemiologic study from Sweden. Cancer 94:1157–1165

    Article  PubMed  Google Scholar 

  16. Hemminki K, Jiang Y (2002) Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 98:106–109

    Article  CAS  PubMed  Google Scholar 

  17. Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 103:525–530

    Article  CAS  PubMed  Google Scholar 

  18. Makinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Maattanen L, Auvinen A (2002) Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng/ml: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. J Urol 166:1339–1342

    PubMed  Google Scholar 

  19. Dong C, Lonnstedt I, Hemminki K (2001) Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 37:1878–1885

    Article  CAS  PubMed  Google Scholar 

  20. Czene K, Hemminki K (2002) Kidney cancer from the nation-wide Swedish Family-Cancer Database: familial risks and association with second primary malignancies. Kidney Internat 61:1806–1813

    Article  Google Scholar 

  21. Czene K, Hemminki K (2003) Familiary papillary renal cell tumors and subsequent cancers: a nation-wide epidemiological study from Sweden. J Urol 169:1271–1275

    Google Scholar 

  22. Plna K, Hemminki K (2001) Familial bladder cancer in the national Swedish family cancer database. J Urol 166:2129–2133

    CAS  PubMed  Google Scholar 

  23. Hemminki K, Czene K (2002) Age specific and attributable risks of familial prostate carcinoma from the Family-Cancer Database. Cancer 95:1346–1353

    Article  PubMed  Google Scholar 

  24. Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001) The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 40:772–777

    Article  CAS  PubMed  Google Scholar 

  25. Hemminki K, Granström C (2002) Risk for familial breast cancer increases with age. Nature Genet 32:233

    Article  CAS  PubMed  Google Scholar 

  26. Hemminki K, Li X (2003) Familial risk of cancer by site and histopathology. Int J Cancer 103:105–109

    Article  CAS  PubMed  Google Scholar 

  27. Center for Epidemiology (2000) Cancer Incidence in Sweden 1998

  28. Esteve J, Benhamou E, Raymond L (1994) Statistical methods in cancer research, vol. 128. IARC, Lyon

  29. Hemminki K, Mutanen P (2001) Birth order, family size, and the risk of cancer in young and middle-aged adults. Br J Cancer 84:1466–1471

    Article  CAS  PubMed  Google Scholar 

  30. Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391

    Article  CAS  PubMed  Google Scholar 

  31. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1607

    CAS  PubMed  Google Scholar 

  32. Hemminki K, Dong C, Vaittinen P (2001) Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 20:247–257

    Article  CAS  PubMed  Google Scholar 

  33. Hemminki K, Jiang Y (2002) Cancer risks among long-standing spouses. Br J Cancer 86:1737–1740

    Article  CAS  PubMed  Google Scholar 

  34. IARC (2003) Tobacco Smoke and Involuntary Smoking, vol. 83. IARC, Lyon

  35. Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, et al (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343:78–85

    CAS  PubMed  Google Scholar 

  36. Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mut Res 473:11–21

    Article  CAS  Google Scholar 

  37. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36

    Article  CAS  PubMed  Google Scholar 

  38. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen A, Fossa S (1996) Familial testicular cancer in Norway and southern Sweden. Br J Cancer 73:964–969

    CAS  PubMed  Google Scholar 

  39. Westergaard T, Olsen J, Frisch M, Kroman N, Nielsen J, Melbye M (1996) Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int J Cancer 66:627–631

    Article  CAS  PubMed  Google Scholar 

  40. Rapley E, Crockford G, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossa SD et al (2000) Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genet 24:197–200

    Article  CAS  PubMed  Google Scholar 

  41. Hemminki K, Li X, Czene K (2003) Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer (in press)

    Google Scholar 

  42. Maddock I, Moran A, Maher E, Teare M, Norman A, Payne S, et al (1996) A genetic register for von Hippel-Lindau disease. J Med Genet 33:120–127

    CAS  PubMed  Google Scholar 

  43. Maher E, Kaelin W (1997) Von Hippel-Lindau disease. Medicine 76:381–332

    Article  CAS  PubMed  Google Scholar 

  44. Friedrich C (1999) Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 86:2478–2482

    Article  CAS  PubMed  Google Scholar 

  45. Hemminki K, Li X, Collins V (2001) A population-based study of familial central nervous system hemangioblastomas. Neuroepidemiol 20:257–261

    Article  CAS  Google Scholar 

  46. Walsh PC, Partin AW (1997) Family history facilitates the early diagnosis of prostate carcinoma. Cancer 80:1871–1874

    Article  CAS  PubMed  Google Scholar 

  47. de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais Da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schroder FH (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97:237–244

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The Family-Cancer Database was created by linking registers maintained at Statistics Sweden and the Swedish Cancer Registry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kari Hemminki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hemminki, K., Li, X. & Czene, K. Familial risk of urological cancers: data for clinical counseling. World J Urol 21, 377–381 (2004). https://doi.org/10.1007/s00345-003-0375-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-003-0375-7

Keywords

Navigation